FSSAI Botanical Labelling Regulations 2026: Mandatory Warning Statements, Nutraceutical Compliance And FSSAI Labelling Guide

What the FSSAI October 2026 Advisory Means for Nutraceutical Manufacturers, Health Supplement Brands and Food Business Operators

Introduction: What Is the Latest FSSAI Regulatory Update?

The Food Safety and Standards Authority of India (FSSAI), through its advisory dated 15 October 2026, has reiterated the need for Food Business Operators (FBOs) to comply with mandatory warning statements and labelling requirements for plant and botanical ingredients, including their extracts, used in nutraceuticals, health supplements, Food for Special Dietary Use (FSDU), Food for Special Medical Purpose (FSMP), and other applicable regulated food categories.

The advisory highlights instances of non-compliance with cautionary statements prescribed under Schedule IV of the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food and Novel Food) Regulations, 2016.

The requirements are particularly important where specific botanical ingredients carry warnings or restrictions relating to pregnancy, children, or individuals planning to conceive.

For manufacturers, importers, brand owners and other FBOs, the update reinforces the importance of reviewing ingredient specifications, permitted usage levels, product formulations and labels against applicable FSSAI requirements.

Key takeaway: Botanical ingredient compliance is not limited to selecting permitted ingredients. Businesses must also verify the relevant plant part, applicable usage conditions and prescribed warning statements before placing products on the Indian market.

What Does the FSSAI Advisory Require?

The advisory reinforces existing regulatory obligations for applicable food products containing botanical ingredients and their extracts. Businesses should ensure that product formulations and labels meet the relevant requirements of the 2016 regulations and subsequent applicable amendments.

Key compliance requirements

These checks should form part of the product development, regulatory review and label approval process.

Businesses should also consider whether changes to a formulation, ingredient supplier, extract specification or recommended daily intake affect the product's existing compliance status.

Botanical Ingredients and Mandatory Warning Statements

Botanical ingredients are widely used in health supplements, nutraceuticals and specialized food products. However, regulatory conditions can vary according to the botanical species, plant part, preparation, concentration and intended use.

The FSSAI advisory reportedly includes an annexure containing 16 botanical entries with relevant cautionary statements and usage ranges. FBOs should consult the complete official annexure and the applicable regulatory provisions to identify the requirements for each ingredient.

What should businesses check?

Important: Warning requirements must be assessed for the specific botanical ingredient, plant part and regulated use. They should not be interpreted as blanket restrictions on every food product containing the same plant.

FBOs should not assume that a botanical ingredient is automatically compliant merely because it is traditionally used, commercially available or included in a supplier's ingredient catalogue.

Why Is Botanical Labelling Compliance Important?

Mandatory warnings help consumers understand relevant precautions and make informed decisions about product use. Missing or inaccurate information can create consumer-safety concerns and expose businesses to regulatory risk.

Botanical labelling compliance is especially important for products marketed to consumers with specific dietary or health-related needs.

Key benefits of effective compliance include:

• Consumer protection: Communicates prescribed precautions and relevant restrictions.
• Accurate ingredient information: Supports transparency regarding botanical ingredients and plant parts.
• Formulation control: Helps identify ingredients or usage levels that require further regulatory review.
• Claims compliance: Reduces the risk of misleading or prohibited medicinal claims.
• Regulatory readiness: Supports consistent documentation and inspection preparedness.
• Product lifecycle management: Helps maintain compliance when formulations, suppliers or labels change.

Businesses should integrate these checks into their existing quality assurance and regulatory affairs processes rather than treating them as a final artwork review alone.

FSSAI Regulatory Consequences of Non-Compliance

The advisory refers to Sections 23 and 52 of the Food Safety and Standards Act, 2006.

Section 23 addresses packaging and labelling requirements for food products, while Section 52 concerns penalties for misbranded food.

Failure to comply with applicable requirements may result in regulatory action, depending on the nature of the violation and the relevant legal provisions. The advisory also warns of potential consequences affecting FSSAI licenses where legally applicable.

Potential areas of regulatory exposure

The applicable consequences depend on the facts and the law. Businesses should not assume that every labelling deficiency automatically results in license suspension or cancellation.

What Should Food Business Operators Do Now?

Manufacturers, importers, nutraceutical companies, health supplement brands and other concerned FBOs should conduct a documented compliance review of relevant products.

Recommended FSSAI compliance checklist

Businesses should priorities products with missing or potentially incorrect warning statements and determine whether label revisions, formulation changes or other corrective measures are required.

The advisory reiterates existing requirements; it should not be interpreted as introducing a separate transition period unless the official document expressly provides one.

Imported Nutraceuticals and Supplier Compliance

Imported health supplements and nutraceuticals marketed in India must meet the Indian regulatory requirements applicable to their product category. Compliance in the country of manufacture does not, by itself, establish compliance with FSSAI requirements.

Importers and brand owners should obtain appropriate ingredient specifications, composition details and supporting documentation from suppliers.

They should also verify that product labels intended for the Indian market contain all applicable declarations and warning statements.

A supplier's general statement that an ingredient is natural, herbal or compliant in another jurisdiction is not a substitute for a product-specific Indian regulatory assessment.

How Maven Regulatory Solutions Can Help

Maven Regulatory Solutions supports businesses seeking to strengthen regulatory compliance across food, nutraceutical and consumer-product categories.

Our support can include:

• FSSAI regulatory compliance assessments for applicable food categories.
• Botanical ingredient reviews covering identity, plant parts and applicable regulatory conditions.
• Nutraceutical and health supplement compliance assessments.
• Food label compliance reviews, including mandatory warning statements and declarations.
• Permitted usage assessments against applicable regulatory requirements.
• Product claims review to identify potentially non-compliant claims.
• Regulatory gap assessments and corrective-action planning.
• Supplier compliance assessments and ingredient documentation reviews.
• Regulatory intelligence to support ongoing monitoring of applicable requirements.
• Product lifecycle compliance support for formulation, label and supplier changes.

Our approach connects ingredient-level regulatory review with formulation controls, labelling requirements and documented compliance processes.

By identifying gaps early, businesses can make informed decisions about corrective actions and strengthen their readiness for regulatory scrutiny.

Frequently Asked Questions (FAQs)

1. What is the FSSAI advisory dated 15 October 2026 about?

According to the information provided, the advisory reiterates compliance with mandatory warning statements and labelling requirements for specified plant and botanical ingredients, and their extracts used in applicable nutraceuticals and specialized food categories.

2. Are warning statements mandatory for every botanical ingredient?

No. Specific cautionary statements apply where prescribed by the relevant regulations. Requirements should be assessed for the ingredient, plant part and intended use.

3. Does the advisory introduce new botanical ingredients or usage limits?

The advisory is described as reinforcing existing requirements. It should not be treated as a new approval list or blanket authorization to use additional botanical ingredients.

4. Are imported nutraceuticals covered?

Imported products must comply with the Indian food safety and labelling requirements applicable to their product category.

5. Can nutraceuticals claim to cure diseases?

Food products must not make prohibited medicinal or disease-cure claims. Claims should be reviewed against applicable FSSAI requirements before publication or use.

6. What happens if a mandatory warning is missing?

Non-compliance may attract regulatory action under applicable provisions of the Food Safety and Standards Act, 2006. The consequences depend on the nature of the violation and the applicable law.

7. Should businesses review products already on the market?

Yes. FBOs should review relevant existing formulations and labels, identify deficiencies and implement appropriate corrective actions.

8. Does a compliant ingredient automatically make the finished product compliant?

No. Compliance also depends on factors such as the intended food category, permitted use, applicable intake limits, labelling, warning statements and product claims.

Conclusion: Strengthening FSSAI Botanical Labelling Compliance in 2026

The FSSAI advisory dated 15 October 2026 reinforces the importance of accurate botanical ingredient declarations, prescribed cautionary statements and compliant formulations for applicable nutraceuticals, health supplements and specialized food products.

For manufacturers, importers and brand owners, compliance should begin with ingredient selection and continue through formulation development, label approval, marketing review and post-market product management.

A structured review of botanical ingredients, plant parts, usage conditions and mandatory warnings can help identify gaps before they lead to consumer-safety concerns or regulatory action.

The key takeaway: Effective FSSAI compliance requires more than a label check. It requires a coordinated approach to ingredient verification, formulation control, warning statements and product claims.

Need Assistance with FSSAI Botanical Labelling Compliance?

Maven Regulatory Solutions can help your business assess applicable FSSAI requirements, review botanical ingredients and product labels, identify compliance gaps and strengthen regulatory documentation.

Connect with our regulatory team to support your nutraceutical and health supplement compliance strategy.